Olaparib, a breast cancer drug lacking the side effects of chemotherapy, can target an Achilles heel in prostate cancers with a weakness in their ability to repair damaged DNA, revealed clinical trial results.
from Medindia Health News https://ift.tt/3bNpVEF
No comments
Post a Comment
Thanks for comment via will connect you within 24 hours.